Single User License, Team License, Corporate License
Published January 10, 2018
Smart pills or nootropics are small medical and embedded electronic devices such as sensors, cameras, and trackers. This device can be quickly swallowed and provides a complete evaluation of the gastrointestinal tract.
Global Smart Pills Diagnostics Market share:
The Global Smart Pills Diagnosis market is segmented by target organ, application, and geography. On basics of applications, the most significant percentage is in North America especially the US. Because of the developing technologies, increasing number of patients, and commercialising of smart pills products.
Global Smart Pills Diagnostics Market size:
Global Smart Pills Diagnosis Market is accounted for USD 2.4 billion in 2017 and expected to grow at a CAGR of 17.7% to reach USD 5.1 billion by 2024.
Rise in advanced technologies to treat diseases, increasing number of patients, including the massive presence of smart pills vendors, has driven the marketplace for intelligent pills diagnostics in, North America followed by Europe. In the forecast period, Asia Pacific is going to have the fastest growth rate in the market
Global Smart Pills Diagnostics Market growth:
The market for smart pills diagnostics are driven by factors like rising prevalence of Gastro-Intestinal diseases, preference for minimally invasive surgeries, and technological developments in capsule endoscopes are favouring the overall growth of the global smart pills diagnostics market.
Global Smart Pills Diagnostics Market Industrial Analysis:
Global Smart Pills Diagnostics Market is segmented by the target organ, applications, and geography. Target organ is categorised by the stomach, small intestine, large intestine, and Esophagus. The growth of the market is driven by application segment classified by patient monitoring, diagnostic imaging, drug delivery, and capsule endoscopy.
Global Smart Pills Diagnostics Market Outlook:
Global Smart Pills Diagnostics market is expected to grow at a significant rate over the forecast period and is anticipated to perform well due to awareness regarding chronic diseases and change the diagnostic procedures. Many industries and firms are trying to develop new technologies and make advancements to improve the smart pill diagnostics market.
Global Smart Pills Diagnostics Market Trends:
Olympus Corporation has wholly acquired image Stream Medical Inc. to improve medical solutions to healthcare in April 2017.
Royal Philips has completed the acquisition of The Spectranetics Corporation, U.S.-based vascular intervention and lead management solutions in August 2017.
Global Smart Pills Diagnostics Market Research Reports:
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.4 SWOT Analysis
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
220.127.116.11 Rising prevalence of Gastro-Intestinal diseases.
18.104.22.168 Preference for minimally invasive surgeries
22.214.171.124 Technological developments in capsule endoscopes.
126.96.36.199 Raising ethical issues in medical conditions
188.8.131.52 Lack skilled professionals.
184.108.40.206 High cost.
220.127.116.11 Precisely locate chronic diseases and disorders.
18.104.22.168 Reduce side effects
22.214.171.124 Cost effective pills
Chapter 5 Market Segmentation by Target Organ
5.2 Small Intestine
5.3 Large Intestine
Chapter 6 Market Segmentation by Application
6.1 Patient Monitoring
6.2 Capsule Endoscopy
6.3 Diagnostic Imaging
6.4 Drugs Delivery
Chapter 7 Market Segmentation by Geography
7.1 North America
7.1.2 United States
7.3 Asia Pacific
7.3.5 Australia & New Zealand
7.4 The Middle East and Africa
7.4.2 South Africa
7.4.3 Middle East Countries
7.5 South America
Chapter 8 Competitive Landscape
8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
8.2 Market Share Analysis
8.3 Strategies Adopted By Top Companies
Chapter 9 Company Profiles
9.1 Phillips NV
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiative
9.2 Proteus Digital Health Inc.
9.3 Bio-Images Research Ltd
9.4 Olympus Corporation
9.6 Medtronic Inc.
9.7 Capsovision Inc.
9.8 IntroMedic Co., Ltd.,
9.9 GE Healthcare
9.10 Boston Scientific Corporation
9.11 Given Imaging Ltd
9.13 Medimetrics S.A. De C.V.
9.14 Chongqing Jinshan Science & Technology Group Co., Ltd
9.15 Novartis AG
Chapter 10 Market Estimates and Forecasting
10.1 Market Estimates and Forecasting 2018-2024(USD Million)
10.1.1 Market Estimation and Forecasting by Product Type 2018-2024 (USD Million)
10.1.2 Market Estimates and Forecasting by Application 2018-2024 (USD Million)
10.1.3 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
Chapter 11 Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures